An unusual extranodal T-cell non-Hodgkin lymphoma

Lancet. 2016 Sep 10;388(10049):1127-1128. doi: 10.1016/S0140-6736(16)30447-0.

Authors

Josh T Coats¹, Alasdair D R Mackie², Neil M Kernohan³, Prasad Guntur Ramkumar⁴, Lesley M McMahon⁵, John R Goodlad⁶, Sudhir Tauro⁷

Affiliations

¹ Department of Haematology, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
² Department of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
³ Department of Pathology, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
⁴ Department of Radiology, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
⁵ Department of Genetics, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
⁶ Department of Pathology, Western General Hospital and University of Edinburgh, Edinburgh, UK.
⁷ Department of Haematology, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK. Electronic address: s.tauro@dundee.ac.uk.

PMID: 27628520
DOI: 10.1016/S0140-6736(16)30447-0

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Back Pain / etiology
Biopsy
Bone Marrow Cells / pathology*
Cyclophosphamide / administration & dosage
Delayed Diagnosis*
Diagnosis, Differential
Doxorubicin / administration & dosage
Female
Fever / etiology
Humans
Karyotyping
Lymphoma, T-Cell, Peripheral / complications
Lymphoma, T-Cell, Peripheral / diagnosis*
Lymphoma, T-Cell, Peripheral / drug therapy
Lymphoma, T-Cell, Peripheral / pathology
Prednisone / administration & dosage
Vincristine / administration & dosage

Substances

Vincristine
Doxorubicin
Cyclophosphamide
Prednisone

Supplementary concepts

CHOP protocol